about
Reverse phase protein microarrays advance to use in clinical trialsTumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology GroupUse of biomarkers in ALS drug development and clinical trialsBiomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group.Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.A statistician's perspective on biomarkers in drug development.A matrix approach to guide IHC-based tissue biomarker development in oncology drug discovery.Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohortChallenges of biomarkers in drug discovery and development.
P2860
Q28384553-911C1C69-8F43-4443-9827-2D7126FF009AQ35224434-FC49447F-1DB2-408A-9DB2-79FDBCA02D4BQ36733981-7B968831-6305-4373-8C52-D92B2A6D4974Q36907188-F62041DC-D037-494D-949B-46DEE9E590FEQ37805245-639ADEE7-E5CC-4C27-8BBE-1752AB0D3491Q37960201-917A5E89-417B-4697-BDDF-B71E5AAD3A49Q37967642-4441F54F-DB09-4571-A20A-20F811026381Q38137016-9D3B751F-6405-4C24-B917-EE589ACC3184Q38300326-91A5A5B1-45A1-442C-B13C-8516C6BDFD5CQ41130064-30FE2929-DC74-48C8-B8A0-E5E85EDF76BFQ47949967-E8ABD88F-F457-4131-B558-161B2BE293E2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biomarkers in oncology drug development
@en
Biomarkers in oncology drug development.
@nl
type
label
Biomarkers in oncology drug development
@en
Biomarkers in oncology drug development.
@nl
prefLabel
Biomarkers in oncology drug development
@en
Biomarkers in oncology drug development.
@nl
P2093
P2860
P1433
P1476
Biomarkers in oncology drug development
@en
P2093
Athula Herath
Darren R Hodgson
Dereck Amakye
Glen Clack
Robin D Whittaker
P2860
P356
10.1016/J.MOLONC.2008.12.002
P577
2008-12-11T00:00:00Z